Revenue increased 12.8%
Revenue changed +12.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed +12.8% from the comparable as-filed period.
Operating income changed +256.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Receivables / revenue changed +359 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross profit changed +16.9% from the comparable as-filed period.
Capital expenditure changed +41.5% from the comparable as-filed period.
Cash / debt changed +8465 basis points from the comparable as-filed period.
R&D / revenue changed -432 basis points from the comparable as-filed period.
Free-cash-flow proxy changed -2.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Inventory / revenue changed -144 basis points from the comparable as-filed period.
Debt / revenue changed -573 basis points from the comparable as-filed period.
Net income changed +244.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Research & development changed -9.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed -193 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current ratio changed +7.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Capex / revenue changed +50 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow changed +2.7% from the comparable as-filed period.
Operating cash-flow margin changed -143 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed +9.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
SBC / revenue changed -34 basis points from the comparable as-filed period.
Reported total debt changed -1.4% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
Selling, general & administrative changed +5.3% from the comparable as-filed period.
Stock-based compensation changed +8.3% from the comparable as-filed period.
Debt / assets changed -115 basis points from the comparable as-filed period.
Cost of revenue changed +0.9% from the comparable as-filed period.
Gross debt changed -1.4% from the comparable as-filed period. The change ranks at the 67th percentile of 9 prior comparable changes.
Noncurrent long-term debt changed -1.4% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.